Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Background. With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging. Methods. Patients with infection or colonization due to colistin-resistant A. baumannii were identified at a hospital system in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Qureshi, Zubair A., Hittle, Lauren E., O'Hara, Jessica A., Rivera, Jesabel I., Syed, Alveena, Shields, Ryan K., Pasculle, Anthony W., Ernst, Robert K., Doi, Yohei
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Articles and Commentaries
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462660/
https://ncbi.nlm.nih.gov/pubmed/25632010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ048
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky